Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYPredictive Oncology Announces Closing of $3.074 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesPREV STORYNGM Bio Outlines 2021 Strategic Priorities Across Its Three Therapeutic Area Portfolios, Including Liver and Metabolic Diseases, Retinal Diseases and Oncology